PubMed: Effects of Oral Cannabinoids on Systemic Inflammation and Viral Reservoir Markers in People with HIV on Antiretroviral Therapy: Results of the CTN PT028 Pilot Clinical Trial
The recent CTN PT028 Pilot Clinical Trial has revealed the potential effects of oral cannabinoids on systemic inflammation and viral reservoir markers in people with HIV on antiretroviral therapy (ART). The trial was conducted by the National Institute on Drug Abuse (NIDA) in collaboration with the National Institute of Allergy and Infectious Diseases (NIAID). The … Read more